Draft:Michelle Rozo
| Submission declined on 30 June 2025 by Spinster300 (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 13 June 2025 by MCE89 (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs to Declined by MCE89 17 days ago.
| |
| Submission declined on 5 June 2025 by HilssaMansen19 (talk). This submission appears to be taken from https://www.chinatalk.media/p/biotech-201. Wikipedia cannot accept material copied from elsewhere, unless it explicitly and verifiably has been released to the world under a suitably free and compatible copyright license or into the public domain and is written in an acceptable tone—this includes material that you own the copyright to. You should attribute the content of a draft to outside sources, using citations, but copying and pasting or closely paraphrasing sources is not acceptable. The entire draft should be written using your own words and structure. Declined by HilssaMansen19 25 days ago.
| |
| Submission declined on 17 March 2025 by SafariScribe (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs to Declined by SafariScribe 3 months ago.
| |
| Submission declined on 17 December 2024 by Significa liberdade (talk). This submission appears to be taken from https://insights.crdfglobal.org/breaking-barriers-2024. Wikipedia cannot accept material copied from elsewhere, unless it explicitly and verifiably has been released to the world under a suitably free and compatible copyright license or into the public domain and is written in an acceptable tone—this includes material that you own the copyright to. You should attribute the content of a draft to outside sources, using citations, but copying and pasting or closely paraphrasing sources is not acceptable. The entire draft should be written using your own words and structure. Declined by Significa liberdade 6 months ago.
| |
Comment: Please fix the issues previously stated, and rewrite in your own words in a neutral tone. Kind regards, Spinster300 (talk) 19:33, 30 June 2025 (UTC).
- Comment: Verbatim copy of speech from websites constituting alarming 57.4% violations of copyright. Others are below the alarming level at 37-39 something. Still, it would be better to remove the all of the exact copies of subject's statements. They are not exactly helpful in establishing notability of the subject or otherwise and reads like textbook chapter about someone's opinions. It may be less when names of the commissions are not considered. Draft is about a notable subject and may get accepted when submitted again after removal of copyrighted content. HilssaMansen19Irien1291S • spreading wiki love ~ Message here; no calls 08:27, 5 June 2025 (UTC)
Michelle Rozo is an American molecular biologist and biotechnology policy expert. She has held numerous government positions and serves as the Vice Chair of the National Security Commission on Emerging Biotechnology.[1][2]
Early life
[edit]Dr. Rozo received a Bachelor of Arts in biology from Northwestern University.[3] She received a Doctor of Philosophy in biology from Johns Hopkins University's Cell, Molecular, Developmental Biology and Biophysics Program.[4][5]
Career
[edit]After completing her PhD, Dr. Rozo worked in various government roles, including a civilian job with the U.S. Navy as well as positions in the U.S. Senate and the U.S. State Department.[6][7][8]
After joining the Department of Defense as a Senior Advisor in 2019, in 2020 Dr. Rozo became the Department of Defense's Principal Director for Biotechnology in the Office of the Undersecretary of Defense for Research and Engineering.[9][10][11]
From February 2021 to December 2022, Dr. Rozo was Director of Technology and National Security at the U.S. National Security Council.[4][12][2]
In 2023, Dr. Rozo joined In-Q-Tel as a Vice President of Technology.[13][14]
Dr. Rozo's expertise has been cited in newspapers, journals, and academic works.[15][16][17][18]
National Security Commission on Emerging Biotechnology
[edit]In December 2022, Senator Chuck Schumer appointed Dr. Rozo to the National Security Commission on Emerging Biotechnology.[1][19] In her role as Vice Chair of the Commission, Dr. Rozo has presented at international conferences and represented the Commission publicly to speak about the intersection of emerging biotechnology and national security, particularly regarding biotechnology's convergence with artificial intelligence and U.S. strategic competition with the People's Republic of China.[20][21][22] Dr. Rozo has testified before multiple Congressional and government committees.[23] [24]
In March 2025, Dr. Rozo authored "A Policy Framework for Strengthening U.S.-ROK Collaboration on Biotechnology," a chapter in the National Bureau of Asian Research's report "U.S.-ROK Tech Cooperation: Batteries, Biotech, and Quantum Technologies," emphasizing opportunities for collaboration on emerging biotechnology with the Republic of Korea.[25]
In April 2025, Dr. Rozo testified before the House Armed Services Committee Subcommittee on Cyber, Information Technologies, and Innovation alongside Senator Todd Young.[26] Her testimony focused on the recommendations in the National Security Commission on Emerging Biotechnology's policy report to Congress.[27] Dr. Rozo and her fellow Commissioners stated in their report that the United States has a limited window to act before permanently ceding biotechnology leadership to another country, noting that the report has 50 recommendations on which Congress can act.[28][29][30]
Since publishing the April 2025 report, Dr. Rozo has worked with several members of Congress to raise awareness about biotechnology and relevant policies.[31][32]
References
[edit]- ^ a b "Armed Services Committees Leadership Announces Chair and Vice Chair Selections for National Security Commission on Emerging Biotechnology". House Armed Services Committee - Democrats. 2022-12-30. Retrieved 2024-12-17.
- ^ a b Masson, Gabrielle; Armstrong, Annalee (2023-02-03). "New federal biotech commission taps 12 members—Chutes & Ladders". www.fiercebiotech.com. Retrieved 2025-03-23.
- ^ "Career Talk: A Path to Science Policy | Graduate Student Resource Center (GradPost)". gradpost.ucsb.edu. Retrieved 2024-12-17.
- ^ a b "Breaking Barriers 2024". insights.crdfglobal.org. Retrieved 2024-12-17.
- ^ Arthur Hirsch (2016-07-19). "Johns Hopkins biologists find protein that bolsters growth of damaged muscle tissue". The Hub. Retrieved 2025-03-23.
- ^ Titus, Alexander (2020-08-18). "From Ebola in Africa to biotechnology in Washington DC — with Michelle Rozo". Bioeconomy.XYZ. Retrieved 2024-12-17.
- ^ "Emerging Leaders in Biosecurity Initiative" (PDF). Retrieved 2024-12-18.
- ^ "Michelle Rozo Bio" (PDF). Feb 1, 2025.
- ^ "Dr Michelle Rozo". www.ndia.org. Retrieved 2024-12-17.
- ^ Mandy Mayfield. "Military to Leverage New Biotech Fields to Gain an Edge". www.nationaldefensemagazine.org. Retrieved 2024-12-17.
- ^ McMillan, Tim (2021-02-05). "Army Research Develops 'Living Material' that Interacts with its Environment". The Debrief. Retrieved 2025-02-01.
- ^ "NAWCWD, Amyris collaborate to develop, test high-energy biosynthetic fuel | NAVAIR". www.navair.navy.mil. Retrieved 2024-12-17.
- ^ "2023 Speakers". Vanderbilt University. Retrieved 2024-12-17.
- ^ "Michelle Rozo | German Marshall Fund of the United States". www.gmfus.org. Retrieved 2025-06-29.
- ^ "China's pharma star is rising". www.marketplace.org. Retrieved 2025-06-29.
- ^ "Biotech boom in North Carolina tied to national security, say industry leaders". Carolina Journal -. 2025-06-06. Retrieved 2025-06-29.
- ^ "Building resilience: Enhancing biosafety, biosecurity, and pandemic preparedness". Brookings. Retrieved 2025-06-29.
- ^ Demarest, Colin (2025-04-16). "U.S. trails China in race to utilize biotech on the battlefield". Axios. Retrieved 2025-06-29.
- ^ Jaramillo, Eduardo (2023-02-10). "Biotech could be next for the U.S.-China breakup". The China Project. Retrieved 2025-03-23.
- ^ "U.S.-China Economic and Security Review Commission hearing on "Current and Emerging Technologies in U.S.-China Economic and National Security Competition" Prepared statement by Michelle Rozo, Vice Chair National Security Commission on Emerging Biotechnology" (PDF). February 1, 2024. Retrieved December 17, 2024.
- ^ "COVID-19". The Pandora Report. 2024-12-06. Retrieved 2024-12-17.
- ^ "Genenta's CEO to present at the U.S. Senate meeting on "Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective"". October 23, 2024.
- ^ "Hearing: Current and Emerging Technologies in U.S.-China Competition". www.uscc.gov. Retrieved 2024-12-17.
- ^ "ISAB Report on Biotechnology in the People's Republic of China's Military-Civil Fusion Strategy" (PDF). October 2024.
- ^ "U.S.-ROK Tech Cooperation: Batteries, Biotech, and Quantum Technologies | The National Bureau of Asian Research (NBR)". Retrieved 2025-03-23.
- ^ Dutton, Gail (2025-04-10). "National Commission Outlines Six Ways to Turbocharge U.S. Biotech Innovation Against the Threat from China". GEN - Genetic Engineering and Biotechnology News. Retrieved 2025-06-29.
- ^ "REPORT: National Security Commission on emerging biotechnology urges swift action to protect U.S. National Security". GIANT fm. Retrieved 2025-04-09.
- ^ "How the U.S. Can Seize the Age of Biology featuring Dr. Michelle Rozo | CSIS Events". www.csis.org. Retrieved 2025-04-14.
- ^ BioCentury Video (2025-04-16). Ep. 82 – Act Now or Fall Behind: Michelle Rozo on Biotech's National Security Stakes. Retrieved 2025-06-29 – via YouTube.
- ^ "Instagram". www.instagram.com. Retrieved 2025-06-29.
- ^ Tabeling, Katie (2025-04-22). "NIIMBL aims for millions as new report urges $15B in biotech investment". Delaware Business Times. Retrieved 2025-06-29.
- ^ "Biotech boom in North Carolina tied to national security, say industry leaders". Carolina Journal -. 2025-06-06. Retrieved 2025-06-29.